| Outcome Measures: |
Primary: Cmax, Maximum plasma concentration observed, Day 1 of each period|AUC 0-72h (area under the curve), Truncated AUC 0-72h, Day 1 to Day 3 of each period | Secondary: Time to reach Cmax (tmax), Time to reach Cmax, Day 1 of each period|Terminal half-life (t1/2z), Terminal half-life associated with the terminal slope (λz), Day 1 to Day 7 of each period|Area under the plasma concentration versus time curve (AUClast), Area under the plasma concentration versus time curve calculated using the trapezoidal method from time zero to the real time tlast, Day 1 to Day 7 of each period|Adverse events, Number of participants with adverse events, Day 1 to Day 7 of each period|Electrocardiograms (ECGs), Number of patients with clinically significant changes in electrocardiograms (ECGs), Day 1 to Day 7 of each period|Vital signs, Number of patients with clinically significant changes in vital signs, Day 1 to Day 7 of each period|Clinical laboratory tests, Number of patients with clinically significant changes in clinical laboratory tests, Day 1 to Day 7 of each period|Area under the curve (AUC), Area under the plasma concentration versus time curve extrapolated to infinity, Day 1 to Day 7 of each period
|
